Dr. Lal Path Labs balance sheet

As of Mar 2026

Total assets: ₹3,146cr+15.8% on Mar 2025
Shareholders' equity: ₹2,541cr+15.2% on Mar 2025
Total debt: ₹0.0crNo figure a year before
Cash and investments: ₹665cr+7.4% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	484	336	343	401
	5.5	3.5	4.0	3.0
	32.8	33.4	33.7	0.0
	548	548	548	548
	192	251	303	356
	1.0	0.0	1.7	2.0
	0.1	0.0	0.0	0.1
	209	81.2	31.7	40.1
	209	81.2	31.7	40.2
	87.5	86.6	44.9	40.4
	19.7	13.6	19.5	21.9
	1,579	1,353	1,329	1,413
	43.9	36.1	37.3	33.8
	423	327	114	150
	111	88.1	77.4	70.8
	243	293	361	264
	667	546	469	402
	1.8	1.1	1.3	1.4
	55.8	50.4	47.0	35.7
	1,500	1,305	1,070	923
	22.3	22.4	19.6	16.0
	1,567	1,364	1,127	973
	3,146	2,717	2,456	2,386
Equity
	168	83.6	83.5	83.4
	2,341	2,089	1,766	1,583
	2,508	2,173	1,849	1,666
	33.1	33.8	36.1	33.2
	2,541	2,207	1,885	1,700
Liabilities
	0.0	0.0	0.0	83.3
	145	103	103	130
	145	103	103	213
	2.6	1.9	0.0	0.0
	6.0	3.3	2.4	2.9
	154	108	105	216
	0.0	0.0	83.3	153
	181	199	187	156
	147	112	109	99.2
	328	310	379	409
	73.8	35.2	37.9	29.1
	7.1	13.8	13.3	0.5
	42.0	43.1	34.8	31.6
	451	403	465	470
	605	510	571	686
	3,146	2,717	2,456	2,386
Trade payables — MSME split
	17.1	13.5	—	—
	164	185	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

LALPATHLAB₹1,911.70

Dr. Lal Path Labs Ltd.

· Pharma & Health

₹ CrorePeersMETROPOLIS VIJAYA THYROCARE NATCOPHARM NEULANDLAB NH COHANCE SAILIFEMcap ₹32,040 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	401.0	343.0	335.8	483.8	483.8
+ Capital Work-in-Progress	3.0	4.0	3.5	5.5	5.5
+ Investment Property	0.0	33.7	33.4	32.8	32.8
+ Goodwill	547.8	548.2	548.1	548.2	548.2
+ Other Intangibles	356.2	302.6	251.1	191.5	191.5
+ Intangibles under Development	2.0	1.7	0.0	1.0	1.0
+ Long-term Loans	0.1	0.0	0.0	0.1	0.1
+ Other Non-current Financial Assets	40.1	31.7	81.2	209.3	209.3
Non-current Financial Assets	40.2	31.7	81.2	209.4	209.4
+ Deferred Tax Assets	40.4	44.9	86.6	87.5	87.5
+ Other Non-current Assets	21.9	19.5	13.6	19.7	19.7
Total Non-current Assets	1,412.5	1,329.3	1,353.3	1,579.4	1,579.4
Current Assets
+ Inventories	33.8	37.3	36.1	43.9	43.9
+ Current Investments	149.9	113.8	326.7	422.6	422.6
+ Trade Receivables	70.8	77.4	88.1	110.7	110.7
+ Cash & Cash Equivalents	263.7	360.9	292.6	242.8	242.8
+ Other Bank Balances	401.7	469.4	546.1	666.7	666.7
+ Short-term Loans	1.4	1.3	1.1	1.8	1.8
+ Other Current Financial Assets	35.7	47.0	50.4	55.8	55.8
Current Financial Assets	923.2	1,069.8	1,305.0	1,500.4	1,500.4
+ Other Current Assets	16.0	19.6	22.4	22.3	22.3
Total Current Assets	973.0	1,126.7	1,363.5	1,566.6	1,566.6
Total Assets	2,385.5	2,456.0	2,716.8	3,146.0	3,146.0
Equity
+ Equity Share Capital	83.4	83.5	83.6	167.6	167.6
+ Other Equity / Reserves	1,582.9	1,765.8	2,089.1	2,340.6	2,340.6
Equity — Owners of Parent	1,666.3	1,849.3	2,172.7	2,508.2	2,508.2
+ Minority Interest	33.2	36.1	33.8	33.1	33.1
Total Equity	1,699.5	1,885.4	2,206.5	2,541.3	2,541.3
Liabilities
+ Borrowings — Non-current	83.3	0.0	0.0	0.0	0.0
+ Other Non-current Financial Liab	130.0	103.0	102.6	145.4	145.4
Non-current Financial Liabilities	213.3	103.0	102.6	145.4	145.4
+ Provisions — Non-current	0.0	0.0	1.9	2.6	2.6
+ Deferred Tax Liabilities	2.9	2.4	3.3	6.0	6.0
Non-current Liabilities	216.2	105.4	107.8	154.0	154.0
+ Borrowings — Current	153.3	83.3	0.0	0.0	0.0
+ Trade Payables	156.1	186.6	198.8	180.6	180.6
+ Other Current Financial Liab	99.2	109.3	111.6	147.2	147.2
Current Financial Liabilities	408.6	379.2	310.4	327.8	327.8
+ Provisions — Current	29.1	37.9	35.2	73.8	73.8
+ Current Tax Liabilities	0.5	13.3	13.8	7.1	7.1
+ Other Current Liabilities	31.6	34.8	43.1	42.0	42.0
Current Liabilities	469.8	465.2	402.5	450.7	450.7
Total Liabilities	686.0	570.6	510.3	604.7	604.7
Total Equity & Liabilities	2,385.5	2,456.0	2,716.8	3,146.0	3,146.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	13.5	17.1	17.1
+ Dues to Other Creditors — Current	—	—	185.3	163.5	163.5

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.